CARDIOPROGRESS
Foundation for the advancement of cardiology

World Heart day 2025 World Heart Day is celebrated annually on September 29. Since its inception, the Cardioprogress Foundation has actively collaborated with the World Heart Federation and, to celebrate this occasion, organizes events in various cities across the Russian Federation.

EASD to Feature Major Trial Results, Clinical Guidance The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more.

Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients’ electrocardiograms Scientists have developed a machine learning (ML) model using electrocardiography (ECG) to predict myocardial blood flow reserve (MFR) and assess its predictive value in relation to major adverse cardiovascular events (MACEs). Using 3639 ECG positron emission tomography (PET) and 17,649 pairs of ECG single-photon emission computed tomography data (SPECT), the model is trained using the intelligent swarm intelligence approach and support vector regression (SVR).

New Scanner Creates Highly Detailed, 3D Images of Blood Vessels in Just Seconds A new scanner can provide three-dimensional (3D) photoacoustic images of millimeter-scale veins and arteries in seconds.

Nobel Prize in medicine goes to two American biologists for work on the discovery of microRNA The 2024 Nobel Prize in physiology or medicine has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on the discovery of microRNA, a molecule that governs how cells in the body function.

Diabetes mellitus has been completely cured for the first time in the world For the first time, scientists transplanted stem cells into a woman with type 1 diabetes, after which she began to produce her own insulin. This is the world's first case of treatment using cells taken from the patient's body.

New Hypertension Approach Hits Multiple Targets at Low Dose Single-pill combinations that include three or four antihypertensive medications are the way forward for the management of patients with elevated blood pressure, according to experts evaluating the new approach.

Emerging role of incretin-based therapy as first-line antihypertensives in obesity Obesity is a major global health issue and a leading cause of premature death. The prevalence of obesity has been rising faster than most other known modifiable risk factors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013.

A new app uses smartphone technology to 'uncuff' blood pressure monitoring Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day.

New Blood Pressure Guidelines Lower Treatment Target Simplified and more aggressive targets are among the significant changes to the updated hypertension guidelines released by the European Society of Cardiology.